BTMD - NASDAQ

biote Corp.

BTMD·NASDAQ

$2.11

+5.5%

HealthcareMedical - Care Facilities

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$93.07M

EPS0.8600

P/E Ratio2.45

Earnings Date08/05/2026

107.61M

Assets

-12%

3Y-4.0%

5Y+230.0%

10Y+350.0%

158.01M

Total Liabilities

-30%

3Y-7.0%

5Y+218.0%

10Y+178.0%

-50.40M

Total Equity

-51%

3Y-14.0%

5Y+195.0%

10Y+53.0%

biote Corp. Funding & Solvency Profile

BTMD · NASDAQ

Current Assets

Cash & Cash Equivalents24.12M

Net Receivables6.87M

Inventory19.06M

Other Current Assets4.62M

Total Current Assets55 M

Non-Current Assets

Property, Plant & Equipment13.45M

Goodwill & Intangible Assets10.10M

Long-Term Investments0.00

Other Non-Current Assets4.60M

Total Non-Current Assets18 M

Total Assets

107.61M

Financial Health Analysis

Current Ratio

1.22x

Acceptable liquidity, but monitor closely. Current assets just barely cover current liabilities.

Working Capital

10 M

Positive working capital, but relatively tight. The company should monitor cash flow carefully.

Asset Composition

51% Current

Balanced asset mix between current and non-current assets, typical of many stable businesses.

biote Corp. Balance Sheet

BTMD • NASDAQ

biote Corp. Balance Sheet	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
ASSETS
CURRENT ASSETS
Cash and Cash Equivalents	24.1M	39.3M	89M	79.2M	26.8M	17.2M	10.5M
Cash & Short-Term Investments	24.1M	39.3M	89M	79.2M	26.8M	17.2M	10.5M
Net Receivables	6.9M	7.7M	8.2M	6.9M	5.2M	4.7M	4M
Accounts Receivables	6.9M	7.6M	6.8M	6.9M	5.2M	4.7M	4M
Other Receivables	0.0	71K	1.4M	0.0	0.0	0.0	0.0
Inventory	19.1M	14.8M	17.3M	11.2M	9.6M	4.3M	3.9M
Prepaids	0.0	6.1M	7.6M	3.8M	1.5M	1.6M	884K
Other Current Assets	4.6M	111K	308K	0.0	3.9M	0.0	0.0
Total Current Assets	54.7M	68.1M	122.3M	101.2M	47.1M	27.8M	19.3M
NON-CURRENT ASSETS
Property, Plant, and Equipment (Net)	13.5M	10.2M	3.1M	3.6M	2.7M	2.2M	2.8M
Goodwill	5.8M	5.8M	0.0	0.0	0.0	0.0	0.0
Intangible Assets	4.3M	9.4M	5M	5.1M	4.6M	2.6M	1.8M
Goodwill & Intangible Assets	10.1M	15.2M	5M	5.1M	4.6M	2.6M	1.8M
Tax Assets	24.8M	28.7M	24.9M	1.8M	0.0	0.0	0.0
Other Non-Current Assets	4.6M	72K	0.0	0.0	0.0	0.0	-4.6M
Total Non-Current Assets	52.9M	54.2M	33M	10.5M	7.2M	4.8M	4.6M
Total Assets	107.6M	122.4M	155.3M	111.6M	54.3M	32.6M	23.9M
LIABILITIES
CURRENT LIABILITIES
Total Payables	6.8M	5.8M	4.2M	5.2M	4.3M	2.4M	3.2M
Accounts Payable	6.8M	5.8M	4.2M	4.1M	4.3M	2.4M	3.2M
Other Payables	0.0	0.0	17K	1.1M	0.0	0.0	0.0
Accrued Expenses	0.0	5.6M	2.4M	1M	3.8M	623K	2.5M
Short Term Debt	6.8M	6.3M	6.3M	6.3M	5M	5M	5M
Capital Lease Obligations (Current)	0.0	523K	311K	165K	248K	239K	230K
Tax Payables	0.0	0.0	17K	1.1M	0.0	0.0	0.0
Deferred Revenue	3M	3M	3M	2M	1.7M	2M	0.0
Other Current Liabilities	28.3M	30.3M	6.1M	4.2M	2.2M	1.4M	2.6M
Total Current Liabilities	45M	51.5M	22.2M	18.8M	17.3M	11.7M	13.5M
NON-CURRENT LIABILITIES
Long Term Debt	100.8M	101.2M	106.6M	112.1M	32M	36.7M	41.5M
Deferred Revenue (Non-Current)	1.1M	1.6M	1.3M	926K	802K	836K	0.0
Other Non-Current Liabilities	8.8M	67.4M	60M	36.2M	0.0	0.0	1.2M
Total Non-Current Liabilities	113M	173.1M	169.6M	151.2M	32.9M	38M	43.3M
Capital Lease Obligations	2.3M	3.4M	2M	2.1M	375K	614K	844K
Total Liabilities	158M	224.6M	191.8M	169.9M	50.2M	49.7M	56.8M
SHAREHOLDERS' EQUITY
Treasury Stock	-9M	-5.6M	0.0	0.0	0.0	0.0	0.0
Common Stock	4K	4K	6K	6K	0.0	0.0	0.0
Retained Earnings	-49.5M	-100.3M	-29.4M	-44.5M	4.2M	-17.1M	-32.9M
Accumulated Other Comprehensive Income/Loss	-29K	-35K	-12K	-5K	-40K	-23K	-33K
Total Stockholders' Equity	-58.5M	-105.9M	-29.4M	-44.5M	4.1M	-17.1M	-32.9M
Total Equity	-50.4M	-102.2M	-36.5M	-58.3M	4.1M	-17.1M	-32.9M
Minority Interest	8.1M	3.7M	-7.1M	-13.8M	0.0	0.0	0.0
SUMMARY
Total Liabilities & Equity	107.6M	122.4M	155.3M	111.6M	54.3M	32.6M	23.9M
Total Debt	109.9M	110.9M	114.9M	120.4M	37.3M	42.4M	47.1M
Net Debt	85.8M	71.5M	25.9M	41.2M	10.6M	25.1M	36.6M
Shares Outstanding	47,851,304	47,851,304	47,851,304	47,851,304	47,851,304	47,851,304	47,851,304

SEC Filings

BTMD - Filing history and reports

Filing Type	Filing Date	Period Ending	Fiscal Year	Actions
8-K 8-K 2026 N/A	June 02, 2026	May 27, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 18, 2026	May 12, 2026	2026	View Filing
10-Q 10-Q 2026 Q1 Q1	May 11, 2026	March 31, 2026	2026	View Filing
8-K 8-K 2026 N/A	May 06, 2026	May 06, 2026	2026	View Filing
DEF 14A DEF 14A 2026 N/A	April 02, 2026	May 12, 2026	2026	View Filing

Showing 1 to 5 of 5 filings

Related Guides

Blog Categories

Continue your BTMD research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.